Value of (18)F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

BACKGROUND: Neoadjuvant systemic therapy (NST) is a widely accepted initial treatment modality that can lead to pathologic downstaging of the axillary disease burden in breast cancer patients. Axillary response as well as baseline (18)F-fluorodeoxyglucose ((18)F-FDG) uptake on positron emission tomo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mooij, Cornelis M., Mitea, Cristina, Mottaghy, Felix M., Smidt, Marjolein L., van Nijnatten, Thiemo J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609064/
https://www.ncbi.nlm.nih.gov/pubmed/34807395
http://dx.doi.org/10.1186/s13550-021-00861-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609064/
https://www.ncbi.nlm.nih.gov/pubmed/34807395
http://dx.doi.org/10.1186/s13550-021-00861-z

Ejemplares similares